期刊文献+

高风险冠心病合并心房颤动抗凝和双联抗栓治疗效果比较 被引量:6

下载PDF
导出
摘要 目的:比较观察高风险冠心病合并心房颤动抗凝和双联抗栓治疗的临床效果。方法:随机抽取巫山县人民医院自2016年2月至2017年2月收治的100例高风险冠心病合并心房颤动患者,根据不同的治疗方法将其分为对照组(n=50)和观察组(n=50)。给予对照组患者双联抗栓治疗,给予观察组患者抗凝治疗,分析两组治疗总有效率、终点不良事件发生率、出血事件发生率、心功能指标。结果:观察组患者治疗总有效率高于对照组,差异具有统计学意义(P <0.05);观察组终点不良事件发生率、出血事件发生率低于对照组,差异具有统计学意义(P <0.05);观察组心功能指标优于对照组,差异具有统计学意义(P <0.05)。结论:在高风险冠心病合并心房颤动患者临床治疗中,抗凝和双联抗栓治疗均可改善患者临床症状,但前者治疗效果明显高于后者,且终点不良事件发生率、出血事件发生率前者低于于后者,且心功能指标前者优于后者。
机构地区 巫山县人民医院
出处 《深圳中西医结合杂志》 2018年第19期22-23,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献6

二级参考文献35

  • 1许永顺.房颤合并冠心病患者PCI术后抗栓策略分析[J].河北北方学院学报(自然科学版),2014,30(3):116-118. 被引量:5
  • 2范莉娟,吴英.老年非瓣膜病性房颤华法林抗凝治疗临床分析[J].心脑血管病防治,2007,7(4):289-289. 被引量:4
  • 3Camm AJ,Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:The Task Force For the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) [J].Eur Heart J,2010,31 (19) :2369-2429.
  • 4Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation -executive Summary:a report of the American College of Cardiology/American Heart Association Task Force on Practive Guidelines and the European Society of Cardiology Committee for Practive Guidelines. (riting Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation)[J].Eur Heart J,2006,27 (16) : 1979-2030.
  • 5Gage BF,Yan Y,Milligan PE,et al.Clinical classification schemes for predicting hemorrhage:results from the National registry of atrial fibrillation (NRAF)[J].Am Heart J ,2006,51 (3) :713-719.
  • 6Pipilis A, Lazaros G, Tsakonas G, et al. Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral antieoagulation in patients with atrial fibrillation undergoing coronary stenting [J]. Hellenie J Cardiol, 2010, 51 (4): 330-337.
  • 7Ruiz-Nodar JM, Marin F, Hurtado JA, et al. Anticoagulant and anti-platelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis [J]. J Am Coll Cardiol, 2008, 51 (8): 818-825.
  • 8Khurram Z, Chou E, Minutello R, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding [J]. J Invasive Cardiol, 2006, 18 (4): 162-164.
  • 9Konstantino Y, Iakobishvili Z, Porter A, et al. Aspirin, warfarin and a thienopyridine for acute coronary syndromes [J]. Cardiology, 2006, 105 (2): 80-85.
  • 10DeEugenio D, Kolman L, DeCaro M, et al. Risk of major bleeding with concomitant dual antiplatelet therapy after pereutaneous coronary intervention in patients receiving long-term warfarin therapy [J]. Phannacotherapy, 2007, 27 (5): 691-696.

共引文献32

同被引文献61

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部